Trinity Biotech (NASDAQ:TRIB) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com started coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Free Report) in a research report issued to clients and investors on Friday. The brokerage set a “buy” rating on the stock. Trinity Biotech Trading Down 6.6 % Shares of NASDAQ TRIB opened at $0.44 on Friday. Trinity Biotech has a […]

Leave a Reply

Your email address will not be published.

Previous post New books to get you through the winter
Next post Thryv (NASDAQ:THRY) Earns Buy Rating from Needham & Company LLC